Latest in Sanofi
Sort by
2 items
-
Teva Soars, Sanofi Gains on Strong Trial Results for IBD Treatment
Duvakitug was generally well tolerated across patient groups and showed similar rates of treatment-emergent adverse events, according to the companies.The Wall Street Journal - 16h -
Sanofi to Invest $1 Billion in New Insulin Manufacturing Base in China
The new base, which will be located in Yizhuang, Beijing, marks Sanofi’s second production site in the capital and its fourth in the country.The Wall Street Journal - Dec. 3
